Literature DB >> 18438547

[Pancreas and islet transplantation in patients with diabetes mellitus].

João Roberto de Sá1, Adriano Miziara Gonzalez, Cláudio Santiago Melaragno, David Saitovich, Denise Reis Franco, Erika Bevilaqua Rangel, Irene Lourdes Noronha, José Osmar Medina Pestana, Marcelo Casaccia Bertoluci, Marcelo Linhares, Marcelo Perosa de Miranda, Patricia Monteagudo, Tércio Genzini, Freddy Goldberg Eliaschewitz.   

Abstract

Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.

Entities:  

Mesh:

Year:  2008        PMID: 18438547     DOI: 10.1590/s0004-27302008000200024

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  4 in total

Review 1.  Islet transplantation in type I diabetes mellitus.

Authors:  Ryan M Jamiolkowski; Lucie Y Guo; Yun Rose Li; Sydney M Shaffer; Ali Naji
Journal:  Yale J Biol Med       Date:  2012-03-29

Review 2.  Human islet xenotransplantation in rodents: A literature review of experimental model trends.

Authors:  Leandro Ryuchi Iuamoto; André Silva Franco; Fábio Yuji Suguita; Felipe Futema Essu; Lucas Torres Oliveira; Juliana Mika Kato; Matheus Belloni Torsani; Alberto Meyer; Wellington Andraus; Eleazar Chaib; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2017-04       Impact factor: 2.365

3.  The evolution of diabetic chronic complications after pancreas transplantation.

Authors:  João R de Sá; Patricia T Monteagudo; Erika B Rangel; Cláudio S Melaragno; Adriano M Gonzalez; Marcelo M Linhares; Alcides Salzedas; Maria-Deolinda F Neves; Camila Stela; José O Medina-Pestana
Journal:  Diabetol Metab Syndr       Date:  2009-09-28       Impact factor: 3.320

4.  Deletion of ARNT (Aryl hydrocarbon receptor nuclear translocator) in β-cells causes islet transplant failure with impaired β-cell function.

Authors:  Amit Lalwani; Rebecca A Stokes; Sue Mei Lau; Jenny E Gunton
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.